Prince Akwasi Mensah

Array ( [id] => 993753 [patent_doc_number] => 06916852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Method for regulation of microvascular tone' [patent_app_type] => utility [patent_app_number] => 10/436028 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 5784 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916852.pdf [firstpage_image] =>[orig_patent_app_number] => 10436028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7605271 [patent_doc_number] => 07115658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Inhibitors of hepatitis C virus RNA-dependent RNA polymerase' [patent_app_type] => utility [patent_app_number] => 10/434702 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54693 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115658.pdf [firstpage_image] =>[orig_patent_app_number] => 10434702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6959709 [patent_doc_number] => 20050215611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Combination therapy for treating cyclooxygenase-2 mediated diseases in patients at risk of thrombotic cardiovascular events' [patent_app_type] => utility [patent_app_number] => 10/513085 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5533 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215611.pdf [firstpage_image] =>[orig_patent_app_number] => 10513085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7453188 [patent_doc_number] => 20040067915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Method to treat cardiofibrosis with a combination of an angiotensin II antagonist and spironolactone' [patent_app_type] => new [patent_app_number] => 10/429410 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15100 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067915.pdf [firstpage_image] =>[orig_patent_app_number] => 10429410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 993750 [patent_doc_number] => 06916849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Compositions for improving lipid content in the blood' [patent_app_type] => utility [patent_app_number] => 10/428558 [patent_app_country] => US [patent_app_date] => 2003-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3062 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916849.pdf [firstpage_image] =>[orig_patent_app_number] => 10428558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7201300 [patent_doc_number] => 20050165112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Therapeutic agent for inflammatory intestinal diseases containing hydroxamic acid compound as active ingredient' [patent_app_type] => utility [patent_app_number] => 10/512341 [patent_app_country] => US [patent_app_date] => 2003-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3351 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165112.pdf [firstpage_image] =>[orig_patent_app_number] => 10512341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070152 [patent_doc_number] => 20050245537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Use of compounds having ccr antagonism' [patent_app_type] => utility [patent_app_number] => 10/511112 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69412 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245537.pdf [firstpage_image] =>[orig_patent_app_number] => 10511112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725536 [patent_doc_number] => 20030207848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Compositions and methods of treating abnormal cell proliferation' [patent_app_type] => new [patent_app_number] => 10/420106 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7007 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 383 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207848.pdf [firstpage_image] =>[orig_patent_app_number] => 10420106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7191060 [patent_doc_number] => 20040204466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Treatment of bronchial asthma using 5-HT3 receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/412686 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2085 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204466.pdf [firstpage_image] =>[orig_patent_app_number] => 10412686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725632 [patent_doc_number] => 20030207944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Aminotetralin derivative for the therapy of cardiovascular diseases' [patent_app_type] => new [patent_app_number] => 10/411313 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3895 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207944.pdf [firstpage_image] =>[orig_patent_app_number] => 10411313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805441 [patent_doc_number] => 20030232835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Prophylactic or therapeutic agents for diseases associated with dysfunction of NOS' [patent_app_type] => new [patent_app_number] => 10/408571 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6942 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232835.pdf [firstpage_image] =>[orig_patent_app_number] => 10408571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6808690 [patent_doc_number] => 20030198629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Ultra-stable composition comprising moringa oil and its derivatives and uses thereof' [patent_app_type] => new [patent_app_number] => 10/410787 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6898 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20030198629.pdf [firstpage_image] =>[orig_patent_app_number] => 10410787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368283 [patent_doc_number] => 20040092562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Methods for treating inflammatory conditions or inhibiting JNK' [patent_app_type] => new [patent_app_number] => 10/407107 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23188 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092562.pdf [firstpage_image] =>[orig_patent_app_number] => 10407107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825606 [patent_doc_number] => 20030236228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Neuropharmacological treatment of sleep-related breathing disorders' [patent_app_type] => new [patent_app_number] => 10/400265 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6276 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236228.pdf [firstpage_image] =>[orig_patent_app_number] => 10400265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711683 [patent_doc_number] => 20030171432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Treating irrtable bowel syndrome or disease' [patent_app_type] => new [patent_app_number] => 10/275270 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3974 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171432.pdf [firstpage_image] =>[orig_patent_app_number] => 10275270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403083 [patent_doc_number] => 20040023843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Preventives/remedies for emotional disorders' [patent_app_type] => new [patent_app_number] => 10/381483 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23000 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023843.pdf [firstpage_image] =>[orig_patent_app_number] => 10381483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404426 [patent_doc_number] => 20040023984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Compounds for the treatment of alzheimer\'s disease' [patent_app_type] => new [patent_app_number] => 10/397682 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10342 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023984.pdf [firstpage_image] =>[orig_patent_app_number] => 10397682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797614 [patent_doc_number] => 20030176488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Method for treating depression' [patent_app_type] => new [patent_app_number] => 10/390967 [patent_app_country] => US [patent_app_date] => 2003-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5490 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176488.pdf [firstpage_image] =>[orig_patent_app_number] => 10390967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209847 [patent_doc_number] => 06713497 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals' [patent_app_type] => B1 [patent_app_number] => 10/389578 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2798 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713497.pdf [firstpage_image] =>[orig_patent_app_number] => 10389578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725625 [patent_doc_number] => 20030207937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => '4-[(8-Substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-yl-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity' [patent_app_type] => new [patent_app_number] => 10/389071 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15876 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207937.pdf [firstpage_image] =>[orig_patent_app_number] => 10389071 [rel_patent_id] =>[rel_patent_doc_number] =>)